TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 48 filers reported holding TRINITY BIOTECH PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,000 | -60.0% | 55,540 | -31.3% | 0.03% | -60.0% |
| Q1 2019 | $230,000 | +26.4% | 80,855 | +1.9% | 0.08% | +13.3% |
| Q4 2018 | $182,000 | -42.6% | 79,365 | 0.0% | 0.08% | -33.0% |
| Q3 2018 | $317,000 | -25.6% | 79,365 | -6.8% | 0.11% | -26.3% |
| Q2 2018 | $426,000 | +191.8% | 85,165 | +200.9% | 0.15% | +181.5% |
| Q1 2018 | $146,000 | -83.0% | 28,300 | -56.4% | 0.05% | -85.2% |
| Q3 2016 | $858,000 | +10.3% | 64,900 | -5.5% | 0.37% | +11.9% |
| Q2 2016 | $778,000 | -3.1% | 68,650 | -0.4% | 0.33% | -4.9% |
| Q1 2016 | $803,000 | +48.2% | 68,900 | +49.5% | 0.34% | +43.3% |
| Q4 2015 | $542,000 | +33.2% | 46,075 | +29.4% | 0.24% | +27.0% |
| Q3 2015 | $407,000 | -38.1% | 35,600 | -2.2% | 0.19% | -32.7% |
| Q2 2015 | $657,000 | -6.3% | 36,400 | -0.1% | 0.28% | -1.1% |
| Q1 2015 | $701,000 | +9.9% | 36,425 | 0.0% | 0.28% | +32.1% |
| Q4 2014 | $638,000 | +34.3% | 36,425 | +40.2% | 0.22% | +32.7% |
| Q3 2014 | $475,000 | – | 25,975 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |